30/09, Startup Exhibition, Cluster „NextGen Health", ST77
Key Facts
Company Description
Dose is revolutionising drug delivery with the world’s first intelligent, programmable transdermal patch. Our “set & forget” system automates dosing, ensures real-time adherence tracking, and delivers safer, more effective treatments for patients and healthcare providers.
Product/Service Description
A smart, programmable patch that automates drug delivery, tracks adherence in real time, and provides seamless, non-invasive treatment for patients and clinicians.
Website
https://dose.com
Crunchbase
https://crunchbase.com/organization/dose-com
Country
United Kingdom
Founding Year
2024
Employees
< 5
Company Stage
MVP/Prototype
Business Model
B2B2C
Focus Industries
Active Markets
(5 most relevant ones)
United Kingdom (current partnerships), Saudi Arabia (public health and allergy resistance initiatives are strategic here)
Look for at Bits & Pretzels
Funding & Investors
3 Lead Investors
Bajaj Ventures LLC, Simon Morris (Chief Creative Officer @ Amazon)
Capital Raised to Date
Last Funding Type
Pre-Seed
Last Funding Date
Capital Need (€)
< 5M
Currently Fundraising
(at the time of Bits & Pretzels 2025)
Yes
Growth Outlook
Traction
Intelligent patch platform with early health collaborations underway.
Monetization Model
Revenue via pharma licensing, clinical trials, providers, and data insights